Antitrust Antitrust

GSK, 31 South Korean pharma companies, distributors fined for bid rigging in vaccine procurement

By Wooyoung Lee
  • 20 Jul 2023 08:02
  • 20 Jul 2023 08:02
GlaxoSmithKline and 31 South Korean pharmaceutical companies and drug distributors were hit with a tentative fine of 40.9 billion won ($32 million) and corrective orders by the South Korean competition regulator for rigging bids in the South Korean government’s vaccine procurement over a period of six years.

The Korea Fair Trade

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Wooyoung Lee

Correspondent, Seoul

Wooyoung Lee is a correspondent based in MLex’s Seoul office, South Korea, covering antitrust, privacy and data security, mergers and acquisitions and financial services. Wooyoung has more than a decade of experience in journalism, public policy and research. She has worked and written for news outlets including The Korea Herald, Al Jazeera International, Bloomberg BNA, Monocle, among others.

Discover MLex

Stay on top of global regulatory developments

Latest News